185 related articles for article (PubMed ID: 22247233)
1. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
[TBL] [Abstract][Full Text] [Related]
2. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
[TBL] [Abstract][Full Text] [Related]
3. Bacterial DNA and endothelial damage in haemodialysis patients.
Merino A; Nogueras S; García-Maceira T; Rodríguez M; Martin-Malo A; Ramirez R; Carracedo J; Aljama P
Nephrol Dial Transplant; 2008 Nov; 23(11):3635-42. PubMed ID: 18511607
[TBL] [Abstract][Full Text] [Related]
4. Microinflammation in hemodialysis is related to a preactivated subset of monocytes.
Ramirez R; Carracedo J; Berdud I; Carretero D; Merino A; Rodríguez M; Tetta C; Martín-Malo A; Aljama P
Hemodial Int; 2006 Jan; 10 Suppl 1():S24-7. PubMed ID: 16441864
[TBL] [Abstract][Full Text] [Related]
5. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 in combination with M-CSF and IL-4 contributes to development of the rare population of CD14+CD16++ cells derived from human monocytes.
Li G; Hangoc G; Broxmeyer HE
Biochem Biophys Res Commun; 2004 Sep; 322(2):637-43. PubMed ID: 15325277
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection.
Castaño D; García LF; Rojas M
Tuberculosis (Edinb); 2011 Sep; 91(5):348-60. PubMed ID: 21621464
[TBL] [Abstract][Full Text] [Related]
8. Elevated CD14++CD16- monocytes predict cardiovascular events.
Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
[TBL] [Abstract][Full Text] [Related]
9. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?
Timmerman KL; Flynn MG; Coen PM; Markofski MM; Pence BD
J Leukoc Biol; 2008 Nov; 84(5):1271-8. PubMed ID: 18664531
[TBL] [Abstract][Full Text] [Related]
10. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients.
Siedlar M; Strach M; Bukowska-Strakova K; Lenart M; Szaflarska A; Węglarczyk K; Rutkowska M; Baj-Krzyworzeka M; Pituch-Noworolska A; Kowalczyk D; Grodzicki T; Ziegler-Heitbrock L; Zembala M
Clin Immunol; 2011 May; 139(2):122-32. PubMed ID: 21300572
[TBL] [Abstract][Full Text] [Related]
11. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
12. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
[TBL] [Abstract][Full Text] [Related]
13. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.
Merino A; Buendia P; Martin-Malo A; Aljama P; Ramirez R; Carracedo J
J Immunol; 2011 Feb; 186(3):1809-15. PubMed ID: 21191073
[TBL] [Abstract][Full Text] [Related]
14. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
15. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
16. Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.
Stec M; Weglarczyk K; Baran J; Zuba E; Mytar B; Pryjma J; Zembala M
J Leukoc Biol; 2007 Sep; 82(3):594-602. PubMed ID: 17595380
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease.
Borges Bonan N; Schepers E; Pecoits-Filho R; Dhondt A; Pletinck A; De Somer F; Vanholder R; Van Biesen W; Moreno-Amaral A; Glorieux G
Sci Rep; 2019 Jul; 9(1):10236. PubMed ID: 31308443
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
20. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.
Rossol M; Kraus S; Pierer M; Baerwald C; Wagner U
Arthritis Rheum; 2012 Mar; 64(3):671-7. PubMed ID: 22006178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
